中天順聯(00994.HK)轉讓建築項目 涉1.8億元
中天順聯(00994.HK)公布,計劃向關連人士捷榮轉讓就塞班項目而訂立的建築合約之所有權利、所有權、權益、利益、契諾、負債、責任及義務,代價約1.8億元。代價中包括3,000萬元現金及於完成時以發行承兌票據的方式支付1.5億元。
公司預期不會就轉讓及約務更替確認任何收益或虧損,而從轉讓及約務更替所得現金款項淨額約為1.89億元(包括承兌票據將累計利息),擬將用於償還銀行貸款及一般營運資金,或日後其他潛在投資機會所需資金之用。
公司將繼續暫停買賣,以待達成聯交所所頒布之復牌指引所列的所有復牌條件。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.